A Prospective Study of an HLA-Haploidentical Peripheral Blood Stem Cell Transplantation Regimen Based on Modification of the Dose of Posttransplant Cyclophosphamide for Poor Prognosis or Refractory Hematological Malignancies

Nakamae, H; Okamura, H; Hirose, A; Koh, H; Nakashima, Y; Nakamae, M; Nishimoto, M; Makuuchi, Y; Kuno, M; Harada, N; Takakuwa, T; Hino, M

Nakamae, H (通讯作者)，Osaka Metropolitan Univ, Grad Sch Med, Hematol, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.

CELL TRANSPLANTATION, 2022; 31 ():

Abstract

The optimal dose of posttransplant cyclophosphamide (PTCy) for use in patients undergoing HLA-haploidentical hematopoietic cell transplantation with p......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索